Advanced search
Publication Cover
Leukemia & Lymphoma Volume 14, 1994 - Issue sup2
Submit an article Journal homepage
14
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Fludarabine in Lymphoproliferative Disorders: The Royal Marsden Hospital Experience

Mary E. R. O'brien Lymphoma Unit and Academic Haematology, Cancer Research Campaign Section of Medicine, The Royal Marsden Hospital, London and Surrey, UK
,
Estella Matutes Lymphoma Unit and Academic Haematology, Cancer Research Campaign Section of Medicine, The Royal Marsden Hospital, London and Surrey, UK
,
David Cunningham Lymphoma Unit and Academic Haematology, Cancer Research Campaign Section of Medicine, The Royal Marsden Hospital, London and Surrey, UK
,
Mark Hill Lymphoma Unit and Academic Haematology, Cancer Research Campaign Section of Medicine, The Royal Marsden Hospital, London and Surrey, UK
,
Elizabeth Emmett Lymphoma Unit and Academic Haematology, Cancer Research Campaign Section of Medicine, The Royal Marsden Hospital, London and Surrey, UK
,
Paul A. Ellis Lymphoma Unit and Academic Haematology, Cancer Research Campaign Section of Medicine, The Royal Marsden Hospital, London and Surrey, UK
,
Sarah Milan Lymphoma Unit and Academic Haematology, Cancer Research Campaign Section of Medicine, The Royal Marsden Hospital, London and Surrey, UK
,
Tamas Hickish Lymphoma Unit and Academic Haematology, Cancer Research Campaign Section of Medicine, The Royal Marsden Hospital, London and Surrey, UK
,
Jane Mercieca Lymphoma Unit and Academic Haematology, Cancer Research Campaign Section of Medicine, The Royal Marsden Hospital, London and Surrey, UK
&
Daniel Catovsky Lymphoma Unit and Academic Haematology, Cancer Research Campaign Section of Medicine, The Royal Marsden Hospital, London and Surrey, UK
 show all
Pages 17-23 | Published online: 01 Jul 2009

References

  • Cabanillas F., Jagannath S., Philip T. Management of recurrent or refractory disease. The Non-Hodgkin's Lymphomas, 1st edition, I. T. MaGrath. Edward Arnold, London 1990; 359–372
  • Radice P. A., Bunn P. A., Ihde D. C. Therapeutic trials with VP-16–213 and VM-26: Active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies. Cancer Treat. Rep. 1979; 63: 1231–1239
  • Grever M. R., Leiby J. M., Kraut E. H., et al. Low dose deoxycoformycin in lymphoid malignancy. J. Clin. Oncol 1985; 3: 1196–1201
  • Piro L. D., Carrera C. J., Beutler E., et al. 2-Chlorodeoxyadenosine: An effective new agent for the treatment of chronic lymphocytic leukemia. Blood 1988; 72: 1069–1073
  • Catovsky D., Fooks J., Richards S. For the MRC Working Party on Leukaemia in Adults. Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. Br. J. Haematol. 1989; 70: 141–149
  • Rai K. R., Sawitsky A., Cronkite E. P., Chanana A. D., Levy R. N., Pasternack B. S. Clinical staging of chronic lymphocytic leukaemia. Blood 1975; 46: 219–234
  • Binet J. L., Catovsky D., Dighiero G., Gale R. P., Montserrat E., Rai K. R., et al. Chronic lymphocytic leukemia: recommendations for diagnosis, staging and response criteria. Ann. Intern. Med. 1989; 110: 236–238
  • Report from the International Workshop on CLL. Chronic lymphocytic leukaemia: proposals for a revised prognostic staging system. Br. J. Haematol. 1981; 48: 365–367
  • Von Hoff D. Phase I clinical trials with fludarabine phosphate. Semin. Oncol. 1990; 17(Suppl 8)33–38
  • Warrell R. P., Berman E. Phase I and II study of fludarabine phosphate in leukemia. Therapeutic efficacy with delayed central nervous system toxicity. J. Clin. Oncol. 1986; 4: 74
  • Grever M. R., Coltman C. A., Files J. L., et al. Fludarabine monophosphate in chronic lymphocytic leukemia. Blood 1986; 68: 223a
  • Redman J. R., Cabanillas F., Velasquez W. S., McLaughlin P., Hagemeister F. B., Swan F., Rodriguez M. A., Plunkett W. K., Keating M. J. Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma. J. Clin. Oncol. 1992; 10: 790–794
  • Kantarjian H. M., Alexanian R., Roller C. A., Kurzrock R., Keating M. J. Fludarabine therapy in macroglobulinemia lymphoma. Blood 1990; 75(10)1928–1931
  • Kaplan E. L., Meier P. Non parametric estimation from incomplete observations. Am. Stat. Assoc. J. 1958; 53: 457–481
  • Feldman E. J., Keating M. J. Fludarabine in the treatment of lymphoproliferative malignancies. Cancer Invest. 1993; 11(3)314–318
  • Hochster H. S., Kim K., Green M. D., Mann R. B., Neiman R. S., Oken M. M., Cassileth P. A., Stott P., Ritch P., O'Connell M. J. Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group Study. J. Clin. Oncol. 1992; 10: 28–32

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.